These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6345457)

  • 21. Evaluation of the efficacy and tolerability of the combination delapril plus indapamide in the treatment of mild to moderate essential hypertension: a randomised, multicentre, controlled study.
    Rosei EA; Rizzoni D;
    J Hum Hypertens; 2003 Feb; 17(2):139-46. PubMed ID: 12574793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Captopril in mild and moderate essential hypertension: physiological and biochemical monitoring.
    Rasmussen S; Leth A; Ibsen H; Damkjaer Nielsen M; Nielsen F; Giese J
    Acta Med Scand Suppl; 1983; 677():105-9. PubMed ID: 6322529
    [No Abstract]   [Full Text] [Related]  

  • 23. [Captopril-a new principle in the treatment of hypertension].
    Forslund T; Fyhrquist F
    Tidsskr Nor Laegeforen; 1981 Aug; 101(23):1290-2. PubMed ID: 7022744
    [No Abstract]   [Full Text] [Related]  

  • 24. Arterial stiffness, hydrochlorothiazide and converting enzyme inhibition in essential hypertension.
    Bénétos A; Laflèche A; Asmar R; Gautier S; Safar A; Safar ME
    J Hum Hypertens; 1996 Feb; 10(2):77-82. PubMed ID: 8867559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Usefulness of orally active angiotensin I converting enzyme inhibitor (SQ 14,225) in the treatment of malignant hypertension.
    Abe I; Kawasaki T; Ueno M; Kawano Y; Uezono K; Ogata M; Kawazoe N; Omae T; Fukiyama K
    Fukuoka Igaku Zasshi; 1980 Mar; 71(3):157-66. PubMed ID: 6247259
    [No Abstract]   [Full Text] [Related]  

  • 26. [Captopril in treatment-resistant hypertension (author's transl)].
    Studer A; Lüscher T; Siegenthaler W; Vetter W
    Schweiz Med Wochenschr; 1980 Dec; 110(51):1987-91. PubMed ID: 7025191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Evaluation of the acute effect of a converting enzyme inhibitor, captopril, in normal and hypertensive subjects].
    Mimran A; Laroche B; Targhetta R; Roumieux JL
    Arch Mal Coeur Vaiss; 1981 Jun; 74 Spec No():61-5. PubMed ID: 6794529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Long term treatment of resistant hypertension with captopril (author's transl)].
    Guedon J; Chaignon M; Lucsko M; Cuche JL; Aubert P; Piete AM
    Nouv Presse Med; 1981 Apr; 10(19):1565-9. PubMed ID: 7025846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Captopril in severe arterial hypertension of childhood (authors transl)].
    Bacri JL; Dechaux M; André JL; Gagnadoux MF; Broyer M
    Arch Fr Pediatr; 1981 Dec; 38 Suppl 1():887-92. PubMed ID: 7036933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Captopril in the therapy of resistant hypertension. A multicenter study].
    Mion Júnior D; Silva HB; Marcondes M
    Arq Bras Cardiol; 1983 May; 40(5):363-7. PubMed ID: 6360101
    [No Abstract]   [Full Text] [Related]  

  • 31. Captopril for hypertension.
    Med Lett Drugs Ther; 1980 May; 22(9):39-40. PubMed ID: 6245345
    [No Abstract]   [Full Text] [Related]  

  • 32. [Captopril inhibits angiotensin converting enzyme. New principles for therapy in hypertension and heart failure].
    Ohman KP; Karlberg BE
    Lakartidningen; 1981 Nov; 78(45):4039-41. PubMed ID: 6276631
    [No Abstract]   [Full Text] [Related]  

  • 33. [Treatment of "therapy-resistant" forms of hypertension with captopril].
    Röckel A; Heidland A
    Med Klin; 1981 Jul; 76(15):427-33. PubMed ID: 7019656
    [No Abstract]   [Full Text] [Related]  

  • 34. [Captopril - profile of a new antihypertensive (author's transl)].
    Gross F
    MMW Munch Med Wochenschr; 1981 Nov; 123(47):1803-9. PubMed ID: 6796855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Current clinical use of converting enzyme inhibitors].
    Corvol P; Plouin PF; Castaigne A; Palsky E
    Rev Prat; 1982 Jan; 32(1):75-82. PubMed ID: 6275488
    [No Abstract]   [Full Text] [Related]  

  • 36. Inhibition of angiotensin-converting enzyme: therapeutic implications.
    Rotmensch HH; Vlasses PH; Ferguson RK
    Isr J Med Sci; 1982 Oct; 18(10):981-5. PubMed ID: 6293997
    [No Abstract]   [Full Text] [Related]  

  • 37. [Comparison of the efficacy of enalapril + hydrochlorothiazide and captopril + hydrochlorothiazide combinations in mild-to-moderate arterial hypertension by ambulatory measurement of blood pressure].
    Mayaudon H; Chanudet X; Janin G; Madonna O
    Ann Cardiol Angeiol (Paris); 1995 May; 44(5):235-41. PubMed ID: 7639505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Captopril: a new method in the treatment of hypertension].
    Radó J; Gercsák G; Pató E; Csabuda M; Molnár Z
    Orv Hetil; 1983 Jul; 124(28):1687-91. PubMed ID: 6350982
    [No Abstract]   [Full Text] [Related]  

  • 39. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Inhibition of the angiotensin I converting enzyme with SQ-14225 (captopril) in the medical treatment of severe renovascular hypertension].
    Martínez Amenós A; Caralps A; Rama H; Sarrias X; Alsina J
    Rev Clin Esp; 1981 Sep; 162(6):265-8. PubMed ID: 7036249
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.